Clinical Trials
All Clinical Trials - Page 65 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00679042Phase 3Active Not Recruiting
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Exenatide
- NCT00613288N/ACompleted
Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
Gonadorelin
- NCT00612794Phase 1Completed
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
Exenatide
- NCT00516074Phase 3Completed
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
Exenatide
- NCT00460304N/ACompleted
The Effect of Pramlintide on Meal Time Insulin Bolus
Pramlintide
- NCT00608023Phase 3Completed
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Tesamorelin
- NCT00603109Phase 3Terminated
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Ghrp-6
- NCT00521781Phase 2Terminated
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
Gonadorelin
- NCT00518882Phase 3Completed
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00516048Phase 3Completed
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
Exenatide
- NCT00508287Phase 1Completed
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
Exenatide
- NCT00819468Phase 1Completed
Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants
Teduglutide
- NCT00324064N/ACompleted
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
Sermorelin
- NCT00505882Phase 4Withdrawn
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Pramlintide
- NCT00502138Phase 4Completed
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
Pramlintide
- NCT00503399Phase 3Completed
Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis
Teriparatide
- NCT00552071Phase 4Completed
Ultrasound Guided Octreotide LAR Injection in Acromegaly
Octreotide
- NCT00510224Phase 2Terminated
Sandostatin for Patients With Androgen Independent Prostate Cancer
Octreotide
- NCT03144271Phase 1Completed
Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
Semaglutide
- NCT00845182Phase 4Completed
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
Exenatide
- NCT00500370Phase 2Completed
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
Exenatide
- NCT01432405Phase 4Completed
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
Exenatide
- NCT00489918Phase 2Completed
Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00471237Phase 2Terminated
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Teriparatide
- NCT00472901N/ACompleted
Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
Afamelanotide
- NCT04053270Phase 3Completed
Multicentre Phase III Erythropoietic Protoporphyria Study
Afamelanotide
- NCT00452556Phase 2Unknown
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
Gonadorelin
- NCT00477581Phase 4Completed
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00467649Phase 4Completed
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Pramlintide
- NCT00477490Phase 3Completed
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
Desmopressin
- NCT00488722N/AUnknown
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer
Gonadorelin
- NCT00456885Phase 4Completed
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
Exenatide
- NCT00518115Phase 2Completed
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
Exenatide
- NCT00542425Phase 2Completed
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00495846Phase 2/Phase 3Completed
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
Octreotide
- NCT00616551Phase 3Completed
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
Octreotide
- NCT00447499Phase 3Completed
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Lanreotide
- NCT00460811Phase 2Completed
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide
- NCT00667732Phase 4Completed
How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
Exenatide
- NCT00456300Phase 2Completed
Role of Exenatide in Type 1 Diabetes
Exenatide
- NCT00720902Phase 4Terminated
Adult Growth Hormone Deficiency and Cardiovascular Risk
Sermorelin
- NCT00444639Phase 2Terminated
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)
Gonadorelin
- NCT01513525Phase 1Completed
Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
Liraglutide
- NCT00434954Phase 3Completed
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
Exenatide
- NCT00442767Phase 4Completed
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
Pramlintide
- NCT00754442N/ACompleted
Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
Teriparatide
- NCT00913055Phase 2Completed
Open Label Study of Octreotide Implant in Patients With Acromegaly
Octreotide
- NCT00422058Phase 2Completed
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
Liraglutide
- NCT07677865N/ACompleted
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Tirzepatide
- NCT00380406Phase 3Completed
PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
Gonadorelin